Officials of the German drugmaker Bayer are on a two-day visit, meeting with startups in biotech and digital health to check out investments and partnerships

A delegation of 15 senior officials of German pharmaceutical giant Bayer AG is visiting Israel this week to seek out partnerships with and possible investments in local startups in the field of biotechnology and digital health.

The delegation is led by Dr. Joerg Moeller, head of Bayer’s international Pharmaceuticals Research & Development Division. He is accompanied by Dr. Berthold Hinzen, head of BD&L Therapeutic Areas, who leads the company’s commercial division and oversees development of startups and companies; Dr. Karl Ziegelbauer, senior vice president, Open Innovation & Digital Technologies; and Jeanne Kehren, head of Bayer’s Digital & Commercial Evaluation, who oversees the Digital Health R&D Division.

Source :

By Shoshanna Solomon